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In this issue, which presents with a specific focus on diabetic 
kidney disease (DKD), Fioretto gathers a series of timely 
reviews providing broad and in-depth insight into DKD and 
its management (https ://doi.org/10.1007/s4062 0-020-00849 
-3). As Fioretto (https ://doi.org/10.1007/s4062 0-020-00797 
-y) says in her presenting editorial, there is an unmet need 
for better treatment options in order to prevent the develop-
ment and slow the progression of DKD. The current dis-
mal scenario is likely to rapidly change with the use of new 
drugs, and furthermore, new therapeutic advances may also 
affect the clinical management of patients with other forms 
of chronic kidney disease.
The reviews, all written by well-known experts in the 
field, touch upon various aspects of DKD, and, besides the 
expected review on GLP-1 receptor antagonists and SGLT2, 
include oxidative stress and omics research, and also cast 
a new light on old issues, such as the role of uric acid or 
atherosclerosis. Along the same lines, Caldara’s editorial 
(https ://doi.org/10.1007/s4062 0-020-00839 -5) reminds us to 
read the position statement of our three societies [the Italian 
Society of Nephrology (SIN), the Italian Society for Organ 
Transplantation (SITO) and the Italian Diabetes Society 
(SID)] on the management of metabolic alterations in adult 
kidney transplant recipients.
The topic collection on kidney and pregnancy is enriched 
by an elegant, albeit still relatively small study reporting the 
effect of diabetes on foetal kidney growth. Indeed, the study 
by Brennan (https ://doi.org/10.1007/s4062 0-020-00815 
-z) elicits a reflection on how pregnancy may be the first 
opportunity towards the prevention of kidney diseases, and 
not only.
Meanwhile, the October issue continues the discussion 
on the impact of the COVID-19 epidemic in the Neph-
rology community. Westhoff and colleagues (https ://doi.
org/10.1007/s4062 0-020-00828 -8) share the experience 
of our German neighbours, and Pio-Abreu (https ://doi.
org/10.1007/s4062 0-020-00823 -z) that of our Brasilian 
friends, confronted with the diffusion of the disease in 
hemodialysis patients. On the same topic, Przedlacki (https 
://doi.org/10.1007/s4062 0-020-00811 -3) comments on the 
fears and expectations of the patients and health care work-
ers towards the testing policies, and Ghiggeri (https ://doi.
org/10.1007/s4062 0-020-00821 -1) summarises the advan-
tages of exploiting our research databases, analysing his 
experience with children and young adults, to gain impor-
tant insights into the impact of the epidemics on different 
cohorts of patients.
Though still recovering from the first COVID-19 wave, 
and while waiting for a second one, life goes on.
We are pleased to share with you our choice of papers 
dealing with clinical nephrology [Binda (https ://doi.
org/10.1007/s4062 0-020-00706 -3) on lupus nephritis, Li 
on IgA nephropathy]. The importance of proteinuria as a 
broad marker of disease risk is highlighted by the papers 
of Ahn (https ://doi.org/10.1007/s4062 0-020-00740 -1) and 
Rahamimov (https ://doi.org/10.1007/s4062 0-020-00703 
-6). In the field of dialysis, Pedrini (https ://doi.org/10.1007/
s4062 0-020-00709 -0) leads an elegant randomised trial sug-
gesting that mixed-dilution hemodiafiltration could reduce 
the erythropoiesis stimulating agents requirement, while an 
intriguing paper by Cuppari (https ://doi.org/10.1007/s4062 
0-020-00819 -9) on peritoneal dialysis underlines the link 
between bowel habits and gut derived toxins, whose level is 
increasingly being associated with several dialysis-related 
outcomes.
In line with the decision to develop further topic col-
lections, in particular on some issues that have charac-
terised the development of nephrology in our country, 
the editorial signed by Cupisti (https ://doi.org/10.1007/
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s4062 0-020-00829 -7) and the new editorial team inaugu-
rates the topic collection on nutritional management in all 
CKD stages, and welcomes a study by Carrero (https ://doi.
org/10.1007/s4062 0-020-00765 -6) on plant-based diets in 
the elderly.
Especially in hard times like ours, a journal should also 
convey some “joie de vivre”; nephrologists are curious phy-
sicians who love facing difficult diagnoses and intriguing 
cases.
With this in mind, please enjoy our nephrology pictures 
and lessons for clinical nephrologists, from four continents 
reporting on some interesting challenges encountered in 
Australia, Taiwan, the US and France.
Stay safe, enjoy reading, and send your best papers to 
Journal of Nephrology.
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